Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Vitamin A treatment reduced abnormal cell growth and improved skin conditions in rats with tumors.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Suppressing ODC activity reduces tumor growth in hair follicles.

Baricitinib was effective in treating alopecia areata in two major trials.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

A cat with hair loss and illness was found to have cancer spread from its colon.

The new fluoroquinolone effectively fights certain bacteria.